Skip to main content

Peer Review reports

From: A single-center, open label, randomized, controlled study of hydroxychloroquine sulfate in the treatment of low risk PLA2R-associated membranous nephropathy

Original Submission
31 Mar 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 May 2024 Reviewed Reviewer Report - Bassam Alchi
2 Jun 2024 Reviewed Reviewer Report
9 Jun 2024 Reviewed Reviewer Report
10 Jun 2024 Reviewed Reviewer Report - Eri Muso
11 Jun 2024 Reviewed Reviewer Report
24 Jun 2024 Author responded Author comments - Bingbing Shen
Resubmission - Version 3
24 Jun 2024 Submitted Manuscript version 3
27 Jun 2024 Author responded Author comments - Bingbing Shen
Resubmission - Version 4
27 Jun 2024 Submitted Manuscript version 4
9 Jul 2024 Author responded Author comments - Bingbing Shen
Resubmission - Version 5
9 Jul 2024 Submitted Manuscript version 5
Publishing
12 Jul 2024 Editorially accepted
19 Jul 2024 Article published 10.1186/s12882-024-03670-3

You can find further information about peer review here.

Back to article page